Dr. Ken Spielvogel

You know, using these drugs without a, to me, a supervised medical professional that's guiding you in terms of what you should be taking on top, how you should be exercising, how you should be, you know, looking at metrics of fitness and longevity, then you're doing yourself a disservice.

And so as a person that's just given it to you.

Today I'm with Dr. Kenneth Spielvogel, Senior Medical Officer at Carrera Treatment Wellness and Spa, to talk about something a lot of people in addiction and mental health are watching closely, GLP-1 medications.

These drugs were created for diabetes and weight loss, but early research shows they may also reduce cravings and relapse risk.

With major new deals dramatically lowering their cost and expanding access, this could become one of the most interesting developments in addiction treatment.

Dr. Spielvogel is here to help break down what's real, what's emerging, and what still needs to be proven.

Dr. Spielvogel, how are you?

How are you, Richard?

How are you doing, buddy?

I'm really happy to be here.

So the first thing I want to say is two years ago, when Carrera started, you told me about the GLP-1s and how it worked for addiction and limited cravings.

And I laughed in your face.

Yes, you did.

You weren't the only one.

Right.

And today I want to say that I was wrong.

You were right.

And I was wrong.

And I apologize.

This is recorded, right?